Centre for Evidence-Based Practice, Tecnológico de Monterrey, School of Medicine, Monterrey, Mexico.
Arch Dis Child. 2011 Aug;96(8):723-8. doi: 10.1136/adc.2010.199307. Epub 2011 May 19.
To evaluate the effect of presenting a recommendation in a clinical practice guideline using different grading systems to determine to what extent the system used changes the clinician's eventual response to a particular clinical question.
Randomised experimental study.
Clinician offices and academic settings.
Paediatricians and paediatric residents in private and public practice in Mexico.
Case notes of a child with diarrhoea and a question about clinician preference for using racecadotril. The same evidence was provided in a clinical recommendation but with different presentations according to the following grading systems: NICE (National Institute for Health and Clinical Excellence), SIGN (Scottish Intercollegiate Guideline Network), GRADE (Grading of Recommendations Assessment, Development and Evaluation) and CEBM (Centre for Evidence-Based Medicine, Oxford).
Mean change in direction from baseline response (measured on a 10 cm visual scale and a Likert scale) and among groups.
216 subjects agreed to participate. Most participants changed their decision after reading the clinical recommendations (mean difference 0.7 cm, 95% CI 0.29 to 1.0; p<0.001). By groups, mean change (95% CI) from baseline was 0.04 (-0.68 to 0.77) for NICE, 0.31 (-0.41 to 1.05) for SIGN, 2.18 (1.48 to 2.88) for GRADE and 0.08 (-0.52 to 0.69) for CEBM (p=0.007 between groups). In a final survey, a small difference was noted regarding the clarity of the results presented with the GRADE system.
The clinician's decision to use a therapy was influenced most by the GRADE system.
NCT00940290.
评估在临床实践指南中使用不同分级系统呈现推荐意见对临床医生对特定临床问题的反应程度的影响,以确定使用的系统在何种程度上发生了变化。
随机实验研究。
墨西哥私人和公共执业医生的诊所以及学术场所。
儿科医生和儿科住院医师。
儿童腹泻病例及关于临床医生使用瑞巴派特倾向的问题。同样的证据在临床推荐中给出,但根据以下分级系统有不同的呈现:NICE(英国国家卫生与临床优化研究所)、SIGN(苏格兰校际指南网)、GRADE(推荐评估、制定与评价分级)和 CEBM(牛津循证医学中心)。
从基线反应(在 10cm 视觉量表和李克特量表上测量)的平均变化方向以及组间差异。
216 名参与者同意参与。大多数参与者在阅读临床推荐后改变了他们的决定(平均差异 0.7cm,95%CI 0.29 至 1.0;p<0.001)。按组划分,从基线开始的平均变化(95%CI)为:NICE 组为 0.04(-0.68 至 0.77)、SIGN 组为 0.31(-0.41 至 1.05)、GRADE 组为 2.18(1.48 至 2.88)和 CEBM 组为 0.08(-0.52 至 0.69)(组间差异 p=0.007)。在最后的调查中,GRADE 系统呈现的结果清晰度方面存在细微差异。
治疗方法的选择受到 GRADE 系统的影响最大。
NCT00940290。